We are live on ! Find out more
SYRS

Syros Pharmaceuticals, Inc. Common Stock

Delisted

SYRS was delisted on the 19th of March, 2025.

Name Holding Trade Value Shares
Change
Change in
Stake
BCLSI
1
Bain Capital Life Sciences Investors
Massachusetts
$7.63M +$4.52M +1,042,290 +96%
AG
2
Artal Group
Luxembourg
$5.25M
FP
3
Flagship Pioneering
Massachusetts
$3.57M
APM
4
Avidity Partners Management
Texas
$3.23M
SB
5
Samsara BioCapital
California
$3.16M
ABG
6
Ally Bridge Group
New York
$3.12M
Adage Capital Partners
7
Adage Capital Partners
Massachusetts
$2.59M
Vanguard Group
8
Vanguard Group
Pennsylvania
$1.7M -$64.2K -14,803 -3%
CH
9
CVI Holdings
Delaware
$1.53M
ACM
10
Altium Capital Management
New York
$1.13M +$1.37M +315,070 New
DCM
11
DAFNA Capital Management
California
$955K
OFM
12
Omega Fund Management
Massachusetts
$902K
BlackRock
13
BlackRock
New York
$746K -$163K -37,514 -15%
Millennium Management
14
Millennium Management
New York
$328K +$94.8K +21,839 +31%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$253K +$438 +101 +0.1%
LCP
16
LGT Capital Partners
Switzerland
$197K
Renaissance Technologies
17
Renaissance Technologies
New York
$170K +$15.2K +3,500 +8%
Susquehanna International Group
18
Susquehanna International Group
Pennsylvania
$155K +$143K +33,042 +324%
LPL Financial
19
LPL Financial
California
$147K +$126K +29,145 +246%
ECM
20
ExodusPoint Capital Management
New York
$123K +$148K +34,165 New
State Street
21
State Street
Massachusetts
$119K -$9 -2 -0%
1CM
22
1492 Capital Management
Wisconsin
$78.1K +$94.3K +21,744 New
CGL
23
Clarius Group LLC
Washington
$67K -$3.15K -727 -4%
E
24
Ergoteles
New York
$65.3K +$78.9K +18,181 New
Acadian Asset Management
25
Acadian Asset Management
Massachusetts
$62K -$29.6K -6,823 -28%